Human Vaccines & Immunotherapeutics, Volume 7, Issue 6 (2011)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Human Vaccines, Volume 7, Issue 6 (2011)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Volume 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editor's Corner

Editorial
Letter from the Editor
Ronald W. Ellis & Eva M. Riedmann
Page: 593
Published online: 01 Jun 2011
CitationforLetter from the Editor | PDF (223.4 KB)
  • 65 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
News
Eva M. Riedmann
Pages: 594-596
Published online: 01 Jun 2011
AbstractforNews | PDF (269.3 KB)
  • 182 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
News
Parents’ vaccination concerns are about more than risk and benefit
Anna K. Mikulak
Pages: 597-599
Published online: 01 Jun 2011
First Page PreviewforParents’ vaccination concerns are about more than risk and benefit | PDF (271.5 KB)
  • 623 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Portrait of a Leading Vaccinologist

Editorial
A passion for global vaccines
Seth Berkley
Pages: 600-603
Published online: 01 Jun 2011
First Page PreviewforA passion for global vaccines | PDF (375.4 KB)
  • 598 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Meeting Report

Meeting Report
Correlates of immune protection: Standardized and automated assays to interrogate correlates of immunity--Phacilitate Vaccine Forum Washington 2011
Wade Bolton
Pages: 604-606
Published online: 01 Jun 2011
AbstractforCorrelates of immune protection: Standardized and automated assays to interrogate correlates of immunity--Phacilitate Vaccine Forum Washington 2011 | PDF (276.7 KB)
  • 120 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Meeting Report
How will diagnostics create new opportunities for prophylactic and therapeutic vaccines?
Niranjan Y. Sardesai
Pages: 607-609
Published online: 01 Jun 2011
AbstractforHow will diagnostics create new opportunities for prophylactic and therapeutic vaccines? | PDF (303.8 KB)
  • 194 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Meeting Report
Improving immunogenicity, efficacy and safety of vaccines through innovation in clinical assay development and trial design: The Phacilitate Vaccine Forum, Washington D.C. 2011
Ioana R. Moldovan & Magdalena Tary-Lehmann
Pages: 610-612
Published online: 01 Jun 2011
AbstractforImproving immunogenicity, efficacy and safety of vaccines through innovation in clinical assay development and trial design: The Phacilitate Vaccine Forum, Washington D.C. 2011 | PDF (257.5 KB)
  • 209 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome
Susanna Esposito, Angelo Selicorni, Cristina Daleno, Antonia Valzano, Marta Cerutti, Carlotta Galeone, Silvia Consolo, Francesca Menni & Nicola Principi
Pages: 613-617
Published online: 01 Jun 2011
AbstractforImmunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome | PDF (314.4 KB)
  • 275 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Muramyl Dipeptide modulates differentiation, maturity of dendritic cells and anti-tumor effect of DC-mediated T cell in acute leukemia children
Ling-zhen Wang, Xiao-ling Li, Xiu-ying Pang & Li-rong Sun
Pages: 618-624
Published online: 01 Jun 2011
AbstractforMuramyl Dipeptide modulates differentiation, maturity of dendritic cells and anti-tumor effect of DC-mediated T cell in acute leukemia children | PDF (2.1 MB)
  • 425 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria
Olumuyiwa. O. Odusanya, Ewan Alufohai, François P. Meurice & Vincent. I. Ahonkhai
Pages: 625-629
Published online: 01 Jun 2011
AbstractforFive-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria | PDF (313.7 KB)
  • 925 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Article
Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms
Tim Ebert, Sharon Smith, Greg Pancari, Xiaoqing Wu, Julie Zorman, Desmond Clark, Jim Cook, Carol Burns, Joseph M. Antonello, Leslie Cope, Eszter Nagy, Andreas Meinke & Tessie McNeely
Pages: 630-638
Published online: 01 Jun 2011
AbstractforDevelopment of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms | PDF (788.4 KB)
  • 489 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: Implications for AIDS vaccine development using Sendai virus vectors
Hiroto Hara, Takashi Hironaka, Makoto Inoue, Akihiro Iida, Tsugumine Shu, Mamoru Hasegawa, Yoshiyuki Nagai, Ann R. Falsey, Anatoli Kamali, Omu Anzala, Eduard J. Sanders, Etienne Karita, Lawrence Mwananyanda, Sandhya Vasan, Angela Lombardo, Christopher L. Parks, Eddy Sayeed, Marietta Krebs, Emmanuel Cormier, James Ackland, Matthew A. Price & Jean-Louis Excler
Pages: 639-645
Published online: 01 Jun 2011
AbstractforPrevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: Implications for AIDS vaccine development using Sendai virus vectors | PDF (1.5 MB)
  • 451 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access
Article
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
Daniela Toneatto, Shevqet Ismaili, Ellen Ypma, Kay Vienken, Philipp Oster & Peter Dull
Pages: 646-653
Published online: 01 Jun 2011
AbstractforThe first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans | PDF (404.3 KB)
  • 752 Views
  • 68 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Hepatitis B vaccination strategy in vaccine low and non-responders: A matter of quantity of quality?
Anna H. Roukens & Leo G. Visser
Pages: 654-657
Published online: 01 Jun 2011
AbstractforHepatitis B vaccination strategy in vaccine low and non-responders: A matter of quantity of quality? | PDF (367.8 KB)
  • 1262 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Synthetic biology: Impact on the design of innovative vaccines
Kathrin Kindsmüller & Ralf Wagner
Pages: 658-662
Published online: 01 Jun 2011
AbstractforSynthetic biology: Impact on the design of innovative vaccines | PDF (322.1 KB)
  • 639 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Increasing pandemic vaccination rates with effective communication
Natalie J. Henrich
Pages: 663-666
Published online: 01 Jun 2011
AbstractforIncreasing pandemic vaccination rates with effective communication | PDF (282.6 KB)
  • 309 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Special Focus Review

Review Article
Vaccines against viral hemorrhagic fevers: Non-human primate models
Ricardo Carrion Jr.Jean L. Patterson
Pages: 667-673
Published online: 01 Jun 2011
AbstractforVaccines against viral hemorrhagic fevers: Non-human primate models | PDF (471.7 KB)
  • 498 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Vaccines for the prevention of dengue: Development update
Stephen J. Thomas & Timothy P. Endy
Pages: 674-684
Published online: 01 Jun 2011
AbstractforVaccines for the prevention of dengue: Development update | PDF (373 KB)
  • 737 Views
  • 52 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Human pathogenic hantaviruses and prevention of infection
Detlev H. Krüger, Günther Schönrich & Boris Klempa
Pages: 685-693
Published online: 01 Jun 2011
AbstractforHuman pathogenic hantaviruses and prevention of infection | Full Text | References | PDF (364.9 KB)
  • 3015 Views
  • 128 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Argentine hemorrhagic fever vaccines
Ana Ambrosio, Maria Saavedra, Mauricio Mariani, Graciela Gamboa & Andrea Maiza
Pages: 694-700
Published online: 01 Jun 2011
AbstractforArgentine hemorrhagic fever vaccines | PDF (534.7 KB)
  • 1203 Views
  • 71 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Filovirius vaccines
Steven B. Bradfute, John M. Dye, Jr.Sina Bavari
Pages: 701-711
Published online: 01 Jun 2011
AbstractforFilovirius vaccines | Full Text | References | PDF (377.9 KB)
  • 798 Views
  • 29 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Risk and safety profile in checkpoint inhibitors on non-small-cel lung cancer: A systematic review
Sara Maria Majernikova
Review Article | Published online: 27 Jun 2024
Open Access
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
Kexuan Cheng et al.
Article | Published online: 27 Jun 2024
Open Access
Knowledge, attitudes, and perceptions of influenza vaccine among pregnant women in Minhang District, Shanghai
Yan Lu et al.
Article | Published online: 27 Jun 2024
Open Access
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccines
Mine Durusu Tanriover et al.
Product Review | Published online: 26 Jun 2024
Open Access